Fungal infections in patients treated with ibrutinib: two unusual cases of invasive aspergillosis and cryptococcal meningoencephalitis

被引：42
作者：
Baron, Marine [1 ]
Zini, Jean Marc [2 ]
Belval, Thibaut Challan [3 ]
Vignon, Marguerite [1 ]
Denis, Blandine [4 ]
Alanio, Alexandre [5 ,6 ,7 ,8 ]
Malphettes, Marion [1 ]
机构：
[1] St Louis Hosp, Dept Immunol, 1 Ave Claude Vellefaux, F-75010 Paris, France
[2] St Louis Hosp, Dept Haematol, Paris, France
[3] Alpes Leman Hosp, Dept Infect Dis, Contamine Sur Arve, France
[4] St Louis Hosp, Dept Infect Dis, Paris, France
[5] St Louis Hosp, Dept Mycol, Paris, France
[6] Paris Diderot Univ, Sorbonne Paris Cite, Dept Mycol, Paris, France
[7] Inst Pasteur, Natl Reference Ctr Invas Mycoses & Antifungals, Mol Mycol Unit, Paris, France
[8] CNRS, URA3012, Paris, France
来源：
LEUKEMIA & LYMPHOMA | 2017年 / 58卷 / 12期
关键词：
CHRONIC LYMPHOCYTIC-LEUKEMIA; ACTIVATION;
D O I：
10.1080/10428194.2017.1320710
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2981 / 2982
页数：2
相关论文
共 15 条
[1]   Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia [J].
Byrd, J. C. ;
Brown, J. R. ;
O'Brien, S. ;
Barrientos, J. C. ;
Kay, N. E. ;
Reddy, N. M. ;
Coutre, S. ;
Tam, C. S. ;
Mulligan, S. P. ;
Jaeger, U. ;
Devereux, S. ;
Barr, P. M. ;
Furman, R. R. ;
Kipps, T. J. ;
Cymbalista, F. ;
Pocock, C. ;
Thornton, P. ;
Caligaris-Cappio, F. ;
Robak, T. ;
Delgado, J. ;
Schuster, S. J. ;
Montillo, M. ;
Schuh, A. ;
de Vos, S. ;
Gill, D. ;
Bloor, A. ;
Dearden, C. ;
Moreno, C. ;
Jones, J. J. ;
Chu, A. D. ;
Fardis, M. ;
McGreivy, J. ;
Clow, F. ;
James, D. F. ;
Hillmen, P. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (03) :213-223
[2]   Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus [J].
Herbst, Susanne ;
Shah, Anand ;
Moya, Maria Mazon ;
Marzola, Vanessa ;
Jensen, Barbara ;
Reed, Anna ;
Birrell, Mark A. ;
Saijo, Shinobu ;
Mostowy, Serge ;
Shaunak, Sunil ;
Armstrong-James, Darius .
EMBO MOLECULAR MEDICINE, 2015, 7 (03) :240-258
[3]   Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib [J].
Jain, Preetesh ;
Keating, Michael ;
Wierda, William ;
Estrov, Zeev ;
Ferrajoli, Alessandra ;
Jain, Nitin ;
George, Binsah ;
James, Danelle ;
Kantarjian, Hagop ;
Burger, Jan ;
O'Brien, Susan .
BLOOD, 2015, 125 (13) :2062-2067
[4]   Advances and issues in mantle cell lymphoma research: report of the 2014 Mantle Cell Lymphoma Consortium Workshop [J].
Kahl, Brad S. ;
Gordon, Leo I. ;
Dreyling, Martin ;
Gascoyne, Randy D. ;
Sotomayor, Eduardo M. .
LEUKEMIA & LYMPHOMA, 2015, 56 (09) :2505-2511
[5]   Concerted Activation of the AIM2 and NLRP3 Inflammasomes Orchestrates Host Protection against Aspergillus Infection [J].
Karki, Rajendra ;
Man, Si Ming ;
Malireddi, R. K. Subbarao ;
Gurung, Prajwal ;
Vogel, Peter ;
Lamkanfi, Mohamed ;
Kanneganti, Thirumala-Devi .
CELL HOST & MICROBE, 2015, 17 (03) :357-368
[6]   Severe pneumonia associated with ibrutinib monotherapy for CLL and lymphoma [J].
Kreiniz, Natalia ;
Bejar, Jacob ;
Polliack, Aaron ;
Tadmor, Tamar .
HEMATOLOGICAL ONCOLOGY, 2018, 36 (01) :349-354
[7]   Ibrutinib, idelalisib and obinutuzumab for the treatment of patients with chronic lymphocytic leukemia: three new arrows aiming at the target [J].
Morabito, Fortunato ;
Gentile, Massimo ;
Seymour, John F. ;
Polliack, Aaron .
LEUKEMIA & LYMPHOMA, 2015, 56 (12) :3250-3256
[8]   Immunosuppression Associated With Novel Chemotherapy Agents and Monoclonal Antibodies [J].
Morrison, Vicki A. .
CLINICAL INFECTIOUS DISEASES, 2014, 59 :S360-S364
[9]   Infectious complications of chronic lymphocytic leukaemia: pathogenesis, spectrum of infection, preventive approaches [J].
Morrison, Vicki A. .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2010, 23 (01) :145-153
[10]   Ibrutinib in Relapsed Chronic Lymphocytic Leukemia [J].
Rushworth, Stuart A. ;
MacEwan, David J. ;
Bowles, Kristian M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (13) :1277-1278
12